X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Cadila Healthcare with Aventis Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs SANOFI INDIA - Comparison Results

CADILA HEALTHCARE    Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

SANOFI INDIA 
   Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE SANOFI INDIA CADILA HEALTHCARE/
SANOFI INDIA
 
P/E (TTM) x 17.6 34.9 50.3% View Chart
P/BV x 3.9 6.0 65.9% View Chart
Dividend Yield % 1.0 1.5 71.4%  

Financials

 CADILA HEALTHCARE   SANOFI INDIA
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-18
SANOFI INDIA
Dec-18
CADILA HEALTHCARE/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs5586,840 8.2%   
Low Rs3624,630 7.8%   
Sales per share (Unadj.) Rs116.31,203.1 9.7%  
Earnings per share (Unadj.) Rs17.9165.3 10.8%  
Cash flow per share (Unadj.) Rs23.1209.9 11.0%  
Dividends per share (Unadj.) Rs3.5084.00 4.2%  
Dividend yield (eoy) %0.81.5 52.0%  
Book value per share (Unadj.) Rs85.4963.6 8.9%  
Shares outstanding (eoy) m1,023.7423.03 4,445.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.04.8 82.9%   
Avg P/E ratio x25.734.7 74.1%  
P/CF ratio (eoy) x19.927.3 72.7%  
Price / Book Value ratio x5.46.0 90.4%  
Dividend payout %19.650.8 38.5%   
Avg Mkt Cap Rs m470,664132,078 356.4%   
No. of employees `00011.83.3 358.0%   
Total wages/salary Rs m18,5454,068 455.9%   
Avg. sales/employee Rs Th10,072.78,393.8 120.0%   
Avg. wages/employee Rs Th1,569.11,232.4 127.3%   
Avg. net profit/employee Rs Th1,547.71,153.0 134.2%   
INCOME DATA
Net Sales Rs m119,04927,708 429.7%  
Other income Rs m1,132897 126.2%   
Total revenues Rs m120,18128,605 420.1%   
Gross profit Rs m28,4756,235 456.7%  
Depreciation Rs m5,3881,027 524.6%   
Interest Rs m9117 13,014.3%   
Profit before tax Rs m23,3086,098 382.2%   
Minority Interest Rs m6280-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,6442,292 246.2%   
Profit after tax Rs m18,2923,806 480.6%  
Gross profit margin %23.922.5 106.3%  
Effective tax rate %24.237.6 64.4%   
Net profit margin %15.413.7 111.9%  
BALANCE SHEET DATA
Current assets Rs m82,00515,922 515.0%   
Current liabilities Rs m60,7206,235 973.9%   
Net working cap to sales %17.935.0 51.1%  
Current ratio x1.42.6 52.9%  
Inventory Days Days7364 114.9%  
Debtors Days Days9821 471.1%  
Net fixed assets Rs m83,7037,539 1,110.3%   
Share capital Rs m1,024230 445.2%   
"Free" reserves Rs m86,42121,962 393.5%   
Net worth Rs m87,44522,192 394.0%   
Long term debt Rs m25,5510-   
Total assets Rs m180,65329,839 605.4%  
Interest coverage x26.6872.1 3.0%   
Debt to equity ratio x0.30-  
Sales to assets ratio x0.70.9 71.0%   
Return on assets %10.612.8 83.2%  
Return on equity %20.917.2 122.0%  
Return on capital %22.027.5 79.9%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m42,6837,587 562.6%   
Fx outflow Rs m11,2427,145 157.3%   
Net fx Rs m31,441442 7,113.3%   
CASH FLOW
From Operations Rs m9,1933,739 245.9%  
From Investments Rs m-9,737-731 1,332.0%  
From Financial Activity Rs m515-1,972 -26.1%  
Net Cashflow Rs m-291,036 -2.8%  

Share Holding

Indian Promoters % 74.8 0.0 -  
Foreign collaborators % 0.0 60.4 -  
Indian inst/Mut Fund % 8.3 14.4 57.6%  
FIIs % 5.9 14.6 40.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 11.0 10.5 104.8%  
Shareholders   44,069 15,184 290.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   SUN PHARMA  MERCK  GSK PHARMA  FULFORD INDIA  DR. REDDYS LAB  

Compare CADILA HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex at New Highs, Jet Airways Suspends Operations - Your Inside Scoop of the Markets(Podcast)

Jet Airways, once India's largest private airline halted its operations indefinitely yesterday. The carrier flew its last scheduled flight from Amritsar to Mumbai yesterday.

Related Views on News

SANOFI INDIA 2017-18 Annual Report Analysis (Annual Result Update)

Apr 16, 2019 | Updated on Apr 16, 2019

Here's an analysis of the annual report of SANOFI INDIA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SANOFI INDIA. Also includes updates on the valuation of SANOFI INDIA.

SANOFI INDIA Announces Quarterly Results (3QFY19); Net Profit Up 4.3% (Quarterly Result Update)

Mar 5, 2019 | Updated on Mar 5, 2019

For the quarter ended December 2018, SANOFI INDIA has posted a net profit of Rs 793 m (up 4.3% YoY). Sales on the other hand came in at Rs 7 bn (up 8.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 3.7% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 3.7% YoY). Sales on the other hand came in at Rs 36 bn (up 9.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

SANOFI INDIA Announces Quarterly Results (2QFY19); Net Profit Up 2.5% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, SANOFI INDIA has posted a net profit of Rs 1 bn (up 2.5% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 18.6% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, CADILA HEALTHCARE has posted a net profit of Rs 4 bn (down 18.6% YoY). Sales on the other hand came in at Rs 30 bn (down 8.4% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

More Views on News

Most Popular

Stocks that Could Be Out of Reach Post Elections(The 5 Minute Wrapup)

Apr 9, 2019

It's a matter of time before the stocks catch the fancy of the markets and big investors.

3 Indian Stocks with Amazon-Like Potential(Profit Hunter)

Apr 10, 2019

We have identified 3 stocks with huge wealth building potential which meet our 'Click of a Button' criteria.

This Company is Making a Big Comeback and You Can Now Profit from Its Example(The 5 Minute Wrapup)

Apr 10, 2019

How Dell got its mojo back.

This is Why the Stock of Jubilant FoodWorks Went Up 1,160%(The 5 Minute Wrapup)

Apr 12, 2019

This critical business strategy has enabled companies to scale their operations faster.

Pocketing Massive Gains with HDFC And HDFC Bank(Profit Hunter)

Apr 12, 2019

Here's how one could have generated gains of Rs 59,250 in 10 days by trading HDFC and HDFC Bank with a capital of Rs 4 lakh.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Apr 18, 2019 (Close)

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE - NATCO PHARMA COMPARISON

COMPARE CADILA HEALTHCARE WITH

MARKET STATS